All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-SARZP13 | Anti-SARS-CoV-2 (COVID-19) S1 (CBN018) h(CD28-CD3ζ) CAR, pCDCAR1 | SARS-CoV-2 (COVID-19) | CBN018 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-SARZP14 | Anti-SARS-CoV-2 (COVID-19) S1 (CBN018) h(4-1BB-CD3ζ) CAR, pCDCAR1 | SARS-CoV-2 (COVID-19) | CBN018 | Rabbit | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-SARZP19 | Anti-SARS-CoV-2 (COVID-19) S1 (CBN015) h(CD28-CD3ζ) CAR, pCDCAR1 | SARS-CoV-2 (COVID-19) | CBN015 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-SARZP20 | Anti-SARS-CoV-2 (COVID-19) S1 (CBN015) h(4-1BB-CD3ζ) CAR, pCDCAR1 | SARS-CoV-2 (COVID-19) | CBN015 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-SARZP21 | Anti-SARS-CoV-2 (COVID-19) S1 (CBN014) h(CD28-CD3ζ) CAR, pCDCAR1 | SARS-CoV-2 (COVID-19) | CBN014 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-SARZP22 | Anti-SARS-CoV-2 (COVID-19) S1 (CBN014) h(4-1BB-CD3ζ) CAR, pCDCAR1 | SARS-CoV-2 (COVID-19) | CBN014 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-SARZP157 | Anti-SARS-CoV-2 (COVID-19) S1 (CBC007) h(CD28-CD3ζ) CAR, pCDCAR1 | SARS-CoV-2 (COVID-19) | CBC007 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-SARZP158 | Anti-SARS-CoV-2 (COVID-19) S1 (CBC007) h(4-1BB-CD3ζ) CAR, pCDCAR1 | SARS-CoV-2 (COVID-19) | CBC007 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-SARZP159 | Anti-SARS-CoV-2 (COVID-19) S1 (CBC006) h(CD28-CD3ζ) CAR, pCDCAR1 | SARS-CoV-2 (COVID-19) | CBC006 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-SARZP160 | Anti-SARS-CoV-2 (COVID-19) S1 (CBC006) h(4-1BB-CD3ζ) CAR, pCDCAR1 | SARS-CoV-2 (COVID-19) | CBC006 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION